XML 57 R31.htm IDEA: XBRL DOCUMENT v3.7.0.1
Segment Information (Tables)
 9 Months Ended
Mar. 31, 2017
Segment Reporting [Abstract]  
Revenue by Reportable Segment
The following table presents revenue for each reportable segment and Corporate:
 
Three Months Ended March 31,
(in millions)
2017
 
2016
Pharmaceutical
$
28,406

 
$
27,527

Medical
3,418

 
3,138

Total segment revenue
31,824

 
30,665

Corporate (1)
(3
)
 
(3
)
Total revenue
$
31,821

 
$
30,662

 
Nine Months Ended March 31,
(in millions)
2017
 
2016
Pharmaceutical
$
86,911

 
$
80,954

Medical
10,107

 
9,220

Total segment revenue
97,018

 
90,174

Corporate (1)
(8
)
 
(12
)
Total revenue
$
97,010

 
$
90,162

(1)
Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.
Segment Profit by Reportable Segment
The following table presents segment profit by reportable segment and Corporate:
 
Three Months Ended March 31,
(in millions)
2017
 
2016
Pharmaceutical
$
611

 
$
660

Medical
148

 
128

Total segment profit
759

 
788

Corporate
(154
)
 
(132
)
Total operating earnings
$
605

 
$
656

 
Nine Months Ended March 31,
(in millions)
2017
 
2016
Pharmaceutical
$
1,682

 
$
1,945

Medical
435

 
335

Total segment profit
2,117

 
2,280

Corporate
(436
)
 
(441
)
Total operating earnings
$
1,681

 
$
1,839
Assets by Reportable Segment
The following table presents total assets for each reportable segment and Corporate at:
(in millions)
March 31,
2017
 
June 30,
2016
Pharmaceutical
$
21,469

 
$
20,662

Medical
10,645

 
10,236

Corporate
2,060

 
3,224

Total assets
$
34,174

 
$
34,122